What are the stages of Chronic Kidney Disease (CKD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Chronic Kidney Disease Stages

Chronic kidney disease is classified into five stages based on glomerular filtration rate (GFR), with Stage 3 further subdivided into 3a and 3b, and complete staging requires incorporating both GFR category and albuminuria category (the CGA classification system) rather than GFR alone. 1, 2

The Five CKD Stages by GFR

Stage 1: GFR ≥90 mL/min/1.73 m²

  • Requires evidence of kidney damage (albuminuria, proteinuria, or structural abnormalities on imaging) since GFR is normal 1, 2
  • Focus on diagnosis and treatment of underlying conditions, slowing progression, and cardiovascular disease risk reduction 2

Stage 2: GFR 60-89 mL/min/1.73 m²

  • Requires evidence of kidney damage (cannot diagnose on GFR alone) 1, 2
  • Emphasize estimating progression rate of kidney disease 2

Stage 3: GFR 30-59 mL/min/1.73 m²

  • Stage 3a: GFR 45-59 mL/min/1.73 m² 1, 2
  • Stage 3b: GFR 30-44 mL/min/1.73 m² 1, 2
  • This subdivision is driven by data demonstrating different outcomes and risk profiles between these GFR ranges, particularly regarding cardiovascular mortality, acute kidney injury risk, and CKD progression 1
  • Begin evaluation and treatment of complications 1, 2
  • Risk of complications (hypertension, anemia, hyperphosphatemia) increases significantly below GFR of 60 mL/min/1.73 m² 1, 2

Stage 4: GFR 15-29 mL/min/1.73 m²

  • Severe decrease in kidney function 1, 2
  • Requires intensive management of complications and preparation for possible kidney replacement therapy 1, 2
  • Hypertension prevalence approaches 80% at this stage 1
  • All patients with Stage 4 CKD should be referred to nephrology 2

Stage 5: GFR <15 mL/min/1.73 m² or dialysis

  • Kidney failure 1, 2
  • Kidney replacement therapy (dialysis or transplantation) required if uremic symptoms develop 1, 2

Critical Diagnostic Requirements

Persistence Criterion

  • Abnormal GFR or kidney damage must persist for at least 3 months for accurate CKD diagnosis 1, 3

GFR Estimation Method

  • Use the CKD-EPI equation for reporting estimated GFR in adults from serum creatinine calibrated to isotope-dilution mass spectrometry reference method 1
  • The CKD-EPI equation demonstrates less bias than the MDRD equation, especially at GFR ≥60 mL/min/1.73 m², with improved precision and greater accuracy 1
  • Never rely on serum creatinine alone—always use prediction equations that account for serum creatinine, age, sex, race, and body size 1

Albuminuria Categories (Essential for Complete Staging)

  • A1: Normal to mildly increased albuminuria 1
  • A2: Moderately increased albuminuria 1
  • A3: Severely increased albuminuria 1
  • An albuminuria level of 30 mg/g represents more than 3 times the normal value in young adults and independently predicts increased risk for CKD complications, cardiovascular mortality, and progression to kidney failure 1

Common Pitfalls to Avoid

Do not classify using GFR alone—use the complete CGA system (Cause, GFR category, Albuminuria category) to avoid incomplete staging and inadequate risk stratification 1

In Stages 1 and 2, evidence of kidney damage (such as albuminuria) is required for CKD diagnosis, while Stages 3-5 can be diagnosed based on GFR alone 1

Do not dismiss age-related GFR decline as "normal aging"—decreased GFR in the elderly remains an independent predictor of adverse outcomes 2

The combination of GFR and albuminuria provides better risk stratification for disease progression and outcomes than either measure alone 1, 3

References

Guideline

Chronic Kidney Disease Staging and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chronic Kidney Disease Staging and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.